Vinod K. Ramani

KR Road
Bengaluru, KA, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

A Rare Presentation of Multiple Myeloma as a Second Primary Cancer Sequential to Non-Hodgkin Lymphoma: Case Report.

A Rare Presentation of Multiple Myeloma as a Second Primary Cancer Sequential to Non-Hodgkin Lymphoma: Case Report.

Journal: Case reports in oncology
Published: July 04, 2025

Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial.

Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial.

Journal: Frontiers in oncology
Published: July 03, 2025

Abrupt Onset of Septic Cardiomyopathy in a Cancer Patient Initiated on Chemotherapy: A Case Report and Literature Review.

Abrupt Onset of Septic Cardiomyopathy in a Cancer Patient Initiated on Chemotherapy: A Case Report and Literature Review.

Journal: Case reports in oncology
Published: June 17, 2025

Co-morbid diabetes mellitus in cancer patients undergoing treatment: a case series and perspective.

Co-morbid diabetes mellitus in cancer patients undergoing treatment: a case series and perspective.

Journal: Frontiers in oncology
Published: April 21, 2025

Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial.

Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer-an open-label phase 2 randomized controlled trial.

Journal: Frontiers in oncology
Published: January 16, 2025

An Open-Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second-Line Therapy for Advanced Head and Neck Squamous Cell Cancers.

An Open-Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second-Line Therapy for Advanced Head and Neck Squamous Cell Cancers.

Journal: Health science reports
Published: April 23, 2024

Decreasing Patient Wait Time by Process Level Interventions in an Oncology Daycare Unit: A Quasi-Experimental Study.

Decreasing Patient Wait Time by Process Level Interventions in an Oncology Daycare Unit: A Quasi-Experimental Study.

Journal: Health science reports
Published: February 26, 2024

Achieving universal health coverage in India: a scoping review on the requisite public health actions.

Achieving universal health coverage in India: a scoping review on the requisite public health actions.

Journal: Frontiers in public health
Published: January 06, 2024

A rare presentation of vanishing bile duct syndrome in Hodgkin lymphoma: Case report.

A rare presentation of vanishing bile duct syndrome in Hodgkin lymphoma: Case report.

Journal: SAGE open medical case reports
Published: May 30, 2023

Effectiveness of meditation on wellness management among corporate employees in India: An interventional study.

Effectiveness of meditation on wellness management among corporate employees in India: An interventional study.

Journal: Health science reports
Published: March 13, 2023

Assessment of Carbon Monoxide in Exhaled Breath using the Smokerlyzer Handheld Machine: A Cross- Sectional Study.

Assessment of Carbon Monoxide in Exhaled Breath using the Smokerlyzer Handheld Machine: A Cross- Sectional Study.

Journal: Tobacco use insights
Published: November 09, 2022

A commentary on cancer prevention and control in India: Priorities for realizing SDGs.

A commentary on cancer prevention and control in India: Priorities for realizing SDGs.

Journal: Health science reports
Published: October 04, 2022
Showing 1-12 of 17

Last Updated: 09/26/2026